5 TIPS ABOUT CLINICAL EFFECTIVENESS OF ABBV-744 IN AML PATIENTS YOU CAN USE TODAY

In Phase A, members will obtain diverse doses and schedules of oral ABBV-744 tablet to identify safe dosing program. More individuals will likely be enrolled in the discovered monotherapy dosign program. In Segment B, contributors will obtain oral ruxolitinib and ABBV-744 will likely be offered as "increase-on" therapy. In Section C, participants w